With a $211.7 billion market value, Pfizer Inc (NYSE:PFE) ranks in the top 10% of its industry group, Pharmaceuticals, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, Portfolio Grader's current ranking for PFE puts it 61 among the 133 companies in this industry group, giving it an above-average position; in the third quartile of the sector with a ranking of 407 among the 783 companies in the sector, and number 2,739 in the nearly 5,000 company Portfolio Grader universe.
Square, Inc. (SQ) has been red-hot, leaving many to expect an impending correction in SQ stock. Next week's earnings could be the start of it.